These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30319138)

  • 1. Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.
    Xu W; Chen F; Fei X; Yang X; Lu X
    Med Sci Monit; 2018 Oct; 24():7357-7365. PubMed ID: 30319138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of G Protein-Coupled Receptor Kinase 6 (GRK6) Is Associated with Progression and Poor Prognosis of Papillary Thyroid Carcinoma.
    Che X; Zhang G; Zhang X; Xue J
    Med Sci Monit; 2018 May; 24():3540-3548. PubMed ID: 29805156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
    Jia M; Guo Y; Lu X
    Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.
    Komatsu S; Ichikawa D; Hirajima S; Nagata H; Nishimura Y; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Imoto I; Inazawa J; Otsuji E
    Br J Cancer; 2015 Jan; 112(2):357-64. PubMed ID: 25321194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of WD Repeat Domain 5 (WDR5) is Associated with Progression and Reduced Prognosis in Papillary Thyroid Carcinoma.
    Xu W; Wang L; An Y; Ye J
    Med Sci Monit; 2019 May; 25():3762-3770. PubMed ID: 31107859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma.
    Zuo SR; Zuo XC; He Y; Fang WJ; Wang CJ; Zou H; Chen P; Huang LF; Huang LH; Xiang H; Liu SK
    J Cancer; 2018; 9(2):321-330. PubMed ID: 29344279
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
    Chen X; Jin J; Zheng L; Sheng Y; Sun J
    J BUON; 2021; 26(1):259-265. PubMed ID: 33721460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of miRNA-200b on the proliferation of liver cancer cells via targeting SMYD2/p53 signaling pathway.
    Fang W; Song L; Li Z; Meng P; Zuo S; Liu S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1303-1314. PubMed ID: 36411681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite Motif Containing 3 inhibits the aggressive behaviors of papillary thyroid carcinoma and indicates lower recurrence risk.
    Song Y; Gao Z; Yan Z; Zheng C
    Genes Genomics; 2022 Apr; 44(4):455-465. PubMed ID: 34860317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma.
    Fei X; Ma Y; Liu X; Meng Z
    Tohoku J Exp Med; 2017 Nov; 243(3):219-226. PubMed ID: 29187705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7.
    Wu L; Kou F; Ji Z; Li B; Zhang B; Guo Y; Yang L
    Cell Death Dis; 2021 May; 12(5):439. PubMed ID: 33935284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.
    Komatsu S; Imoto I; Tsuda H; Kozaki KI; Muramatsu T; Shimada Y; Aiko S; Yoshizumi Y; Ichikawa D; Otsuji E; Inazawa J
    Carcinogenesis; 2009 Jul; 30(7):1139-46. PubMed ID: 19423649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
    Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
    BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of STIP1 in papillary thyroid carcinoma.
    Yuan MH; Zhou RS; She B; Xu HF; Wang JY; Wei LX
    Tumour Biol; 2014 Mar; 35(3):2391-5. PubMed ID: 24163084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of SET and MYND domain-containing protein 2 (
    Zhang P; Ruan J; Weng W; Tang Y
    Leuk Lymphoma; 2020 Feb; 61(2):437-444. PubMed ID: 31612757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
    Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
    Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-127 Predicts Poor Prognosis and Contributes to the Progression of Papillary Thyroid Cancer by Targeting REPIN1.
    Sun Y; Sun W; Hua H; Zhang J; Yu Q; Wang J; Liu X; Dong A
    Horm Metab Res; 2021 Mar; 53(3):197-203. PubMed ID: 33339069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
    Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
    Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.